483 Qilu Tianhe Pharmaceutical Sep 2017

483 Qilu Tianhe Pharmaceutical Sep 2017

Andrew Idzior FDA, Azza Talaat FDA$119.00 - Available Now

FDA investigators audited the Qilu Tianhe Pharmaceutical - Jinan, China facility and issued inspectional observations (via FDA 483) on 01 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Sep 2017
  • Location: Jinan, China
  • FEI: 3004229375
Add To Cart